Literature DB >> 26455059

Use of Systemic Therapies to Manage Focal Hyperhidrosis.

Dee Anna Glaser, Katherine Glaser.   

Abstract

Primary hyperhidrosis (excessive sweating) commonly affects the axillae, palms, soles, scalp, face, and the groin. Patients may have multiple areas involved making localized therapy challenging. Systemic therapy may be necessary and can be used as monotherapy or combined with other hyperhidrosis treatments for optimal outcomes. Systemic therapy can also be used to treat secondary hyperhidrosis and compensatory hyperhidrosis. Patient selection and counseling are key, and monitoring for side effects is required throughout therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26455059      PMCID: PMC6170074     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  22 in total

Review 1.  Generalized hyperhidrosis and its systemic treatment.

Authors:  Roland Böni
Journal:  Curr Probl Dermatol       Date:  2002

2.  Oxybutynin therapy for generalized hyperhidrosis.

Authors:  Ron A Tupker; Ankie M Harmsze; Vera H M Deneer
Journal:  Arch Dermatol       Date:  2006-08

3.  Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.

Authors:  Paula Gish; Andrew D Mosholder; Melissa Truffa; Rosemary Johann-Liang
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

4.  A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.

Authors:  Nelson Wolosker; José Ribas Milanez de Campos; Paulo Kauffman; Pedro Puech-Leão
Journal:  J Vasc Surg       Date:  2012-02-16       Impact factor: 4.268

5.  An epidemiological study of hyperhidrosis.

Authors:  William Lear; Edward Kessler; Nowell Solish; Dee Anna Glaser
Journal:  Dermatol Surg       Date:  2007-01       Impact factor: 3.398

6.  Clonidine treatment of excessive sweating.

Authors:  R Feder
Journal:  J Clin Psychiatry       Date:  1995-01       Impact factor: 4.384

7.  The effect of propranolol versus placebo on resident surgical performance.

Authors:  M J Elman; J Sugar; R Fiscella; T A Deutsch; J Noth; M Nyberg; K Packo; R J Anderson
Journal:  Trans Am Ophthalmol Soc       Date:  1998

8.  [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis].

Authors:  C Try; R Messikh; A Elkhyat; F Aubin; R P Humbert
Journal:  Rev Med Liege       Date:  2012-10

9.  Use of oral glycopyrronium bromide in hyperhidrosis.

Authors:  V Bajaj; J A A Langtry
Journal:  Br J Dermatol       Date:  2007-04-25       Impact factor: 9.302

Review 10.  Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda-Amrita D Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.